Yahoo Finance report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
Why CL Stock surged +2.29% Today — RQD Quant Desk Flash
Colgate-Palmolive Company (CL) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (60% profit margin, 44% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is CL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Colgate-Palmolive Company (NYSE: CL) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $95.29 (+2.29% 1D, market cap $74.26B). Pillar breakdown: Fundamental Cash Engine 19/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 14/20. Across 1011 tracked Consumer Discretionary issuers, CL ranks #143 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does CL compare to ECL and UL in the Consumer Discretionary sector?
▼
Within the Consumer Discretionary sector (Package Goods/Cosmetics), CL carries a Roarable B- (70/100 RQD), trailing P/E of 34.8x, gross margin of 60.1%, and ROIC of 44.0%. By comparison, ECL (Ecolab Inc.) holds a B- grade (71/100 RQD, P/E 40.6x, ROIC 14.1%, cap $84.34B) and UL (Unilever PLC American) posts a C grade (65/100 RQD, P/E 32.8x, ROIC 9.9%, cap $138.26B). Among the 5-stock peer group, UL leads on earnings multiple (32.8x) while CL leads on capital efficiency (44.0% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for CL?
▼
Per CL's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000021665), Colgate-Palmolive Company generated $20.38B in revenue (+1.4% YoY), $2.13B in net income, and $3.28B in free cash flow against $16.33B in total assets and $6.87B in total debt. Key quantitative strengths: Strong cash generator (60% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 16.1% FCF Margin ($3.28B FCF) & 60.1% Gross Margin
20D Institutional Volume Accumulation (±4.2% realized swing band)
Macro rate sensitivity & RSI-14 (54.7) create a -11 pt regime headwind
⚔️ Adversarial Opposing Case: Why the CL Bull Thesis Could Fail
Even with a 70/100 (B-) score, CL faces multiple-compression risk if 34.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Dilution & Margin Drag: Cannibal Buyback (-1.80% YoY Shares) — any gross margin slip below 57.6% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($89.61) or 200D SMA ($89.77) invalidates the momentum regime and cuts Target Base ($100.44) toward Bear Floor ($78.14).
Why CL Stock surged +2.29% Today — RQD Quant Desk Flash
Colgate-Palmolive Company (CL) surged +2.29% to $95.29, trading at 84% of its 52-week range ($74.55 – $99.33). High-quality cash engine (60% profit margin, 44% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 84% of its 52-week range ($74.55 – $99.33) with RSI-14 at 54.7 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±4.2% around $95.29 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B- (Buy) backed by 60.1% gross margin and $3.3B annual free cash flow.
Seeking Alpha report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
24/7 Wall St. report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
Benzinga report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
Colgate-Palmolive’s third quarter was marked by broad-based organic sales growth and a positive market reaction, as management attributed the momentum to strong emerging market demand and continued progress in its premiu
Companies in The News Are: ABBV,XOM,CVX,CL
Scheduled RQD Strong Buys & Whale Accumulation Briefing (CL Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
CL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +1.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CL today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CL. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CL)
1. Head-to-Head Consumer Discretionary Peer Comparison (CL vs. ECL, UL, EL, HLN)
Industry: Package Goods/Cosmetics (23 Tracked Issuers)Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Colgate-Palmolive Company (CL) ranks #143 by composite RQD confidence (70/100, grade B-) and #30 by equity capitalization ($74.26B). Within this direct 5-issuer industry benchmark cohort, UL leads on earnings valuation at 32.8x trailing P/E, while CL leads on capital efficiency and profitability with 44.0% ROIC and 60.1% gross margin. ECL currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with CL at 70/100 (B-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CL
ACTIVE
Colgate-Palmolive Company | B- | 70/100 | 34.8x | 60.1% | 44.0% | +2.29% | $74.26B | Benchmark Subject |
| ECL Ecolab Inc. | B- | 71/100 | 40.6x | 44.5% | 14.1% | +0.71% | $84.34B | /ecl-vs-cl → |
| UL Unilever PLC American | C | 65/100 | 32.8x | — | 9.9% | +1.68% | $138.26B | /ul-vs-cl → |
| EL Estee Lauder Companies Inc. | D+ | 57/100 | — | 74.0% | -11.0% | +0.39% | $39.42B | /el-vs-cl → |
| HLN Haleon plc American | D+ | 55/100 | 32.8x | — | 9.9% | +1.05% | $37.69B | /hln-vs-cl → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000021665In its most recent audited fiscal period (FY2025, filed 2025-12-31), Colgate-Palmolive Company (CL) reported GAAP revenue of $20.38B (+1.4% vs. FY2024 revenue of $20.10B , and +4.8% cumulative change since FY2023) , GAAP net income of $2.13B, operating cash flow of $4.20B, and free cash flow of $3.28B (+2.4% YoY). On the balance sheet, CL closed FY2025 with $16.33B in total assets against $6.87B in total debt (Altman Z-Score: 6.90, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $20.38B | $2.13B | $4.20B | $3.28B | $16.33B | $6.87B |
| FY2024 (FY) | 2024-12-31 | $20.10B | $2.89B | $4.11B | $3.20B | $16.05B | $7.29B |
| FY2023 (FY) | 2023-12-31 | $19.46B | $2.30B | $3.75B | $2.87B | $40.85B | $9.56B |
3. CL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Colgate-Palmolive Company (NYSE: CL) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $95.29 (+2.29% 1D, market cap $74.26B). Pillar breakdown: Fundamental Cash Engine 19/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 14/20. Across 1011 tracked Consumer Discretionary issuers, CL ranks #143 in composite RQD confidence.
How does CL compare to ECL and UL in the Consumer Discretionary sector?
Within the Consumer Discretionary sector (Package Goods/Cosmetics), CL carries a Roarable B- (70/100 RQD), trailing P/E of 34.8x, gross margin of 60.1%, and ROIC of 44.0%. By comparison, ECL (Ecolab Inc.) holds a B- grade (71/100 RQD, P/E 40.6x, ROIC 14.1%, cap $84.34B) and UL (Unilever PLC American) posts a C grade (65/100 RQD, P/E 32.8x, ROIC 9.9%, cap $138.26B). Among the 5-stock peer group, UL leads on earnings multiple (32.8x) while CL leads on capital efficiency (44.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CL?
Per CL's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000021665), Colgate-Palmolive Company generated $20.38B in revenue (+1.4% YoY), $2.13B in net income, and $3.28B in free cash flow against $16.33B in total assets and $6.87B in total debt. Key quantitative strengths: Strong cash generator (60% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CL trading relative to its 50-day, 200-day, and 52-week technical levels?
CL last traded at $95.29 (+2.29% on volume of 8,839,694 shares), positioning the stock +6.34% above its 50-day simple moving average ($89.61) and +6.15% above its 200-day simple moving average ($89.77). Across its 52-week range of $74.55 to $99.33, CL sits at the 83.7% percentile with a 14-day RSI of 54.7 (NEUTRAL RANGE) and an implied next-earnings move of ±4.2% ($91.29 to $99.29).
CL Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CL stock moving today?
Why CL Stock surged +2.29% Today — RQD Quant Desk Flash. High-quality cash engine (60% profit margin, 44% return on capital) with steady institutional support.
CL — Colgate-Palmolive Company: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, CL scores 70 out of 100, a letter grade of B-, with the verdict label "Roarable Buy — Sound Institutional Accumulation." The five pillars are:
- Fundamental Cash Engine: 19 / 20. Per the RQD rating, this reflects ROIC of 44% and an FCF yield of 4.42%. For an investor, this is the strongest pillar and the main source of upside support: high capital efficiency and strong cash generation are the core of the bullish case.
- Whale 13F Flow: 15 / 20. Per the RQD rating, this pillar reflects institutional accumulation and options positioning. Institutional support is a positive signal, though the underlying holder detail is not provided in source data.
- Insider Conviction: 14 / 20. Per the RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. Moderate insider support is noted, but the specific transactions are not itemized in the source data.
- Macro Regime Fit: 9 / 20. Per the RQD rating, this pillar reflects Beta of 1.11 and sector sensitivity. This is the weakest pillar and the main valuation and cyclical tradeoff: the stock carries above-market sensitivity to broad moves, and the rating assigns it limited regime alignment.
- Forensic Balance Sheet: 13 / 20. Per the RQD rating, this reflects Altman Z of 6.9, Piotroski F of 5/9, and Debt/Equity of 8.5. The Altman Z suggests low distress risk; the Piotroski and leverage figures indicate a mixed balance-sheet picture an investor should weigh.
Taken together, the rating's profile is one of strong cash economics and institutional support, offset by macro sensitivity and a balance sheet that is solid on distress measures but mixed on leverage. Valuation is a central tradeoff: per market data, trailing P/E is 34.8 and forward P/E is 32.4, which are elevated relative to the cash-return metrics above. This is an analytical framing, not personalized advice.
Snapshot
Business
Colgate-Palmolive Company (CL) is a NYSE-listed issuer in the Consumer Discretionary sector, Package Goods/Cosmetics industry, per the company profile. Per the market data, the company reports a gross margin of 60.1%, an operating margin of 16.2%, and a net margin of 10.5%. Specific product lines, customer segments, and revenue-generation mechanics beyond sector and industry classification are not available in source data.
Recent Catalysts & News Wire Analysis
Per the recent news feed, the catalyst and risk-watch items are:
- Hill's premium pricing (YELLOW, MARKET WIRE): A Yahoo Finance headline questions whether premium pricing at Hill's can translate into better profits.
- International growth (GREEN, CATALYST): A Seeking Alpha headline describes the company's international growth push as working.
- Overvaluation risk (RED, RISK WATCH): A 24/7 Wall St. headline questions whether the stock is overvalued and references a "hidden risk" tied to October 30.
- Dividend King positioning (YELLOW, MARKET WIRE): A Yahoo Finance headline references hedge fund interest in the stock as a dividend king.
- Institutional position increase (YELLOW, MARKET WIRE): A MarketBeat item reports a firm increasing its position in CL.
- Q3 beat and outlook raise (GREEN, CATALYST): A Benzinga headline reports a Q3 estimate beat and a raised profit outlook despite weak U.S. demand and rising costs.
The butterfly supply-chain graph lists sector as Consumer Discretionary, industry as Package Goods/Cosmetics, supply chain as NONE, with no butterfly links and no proprietary signals. Per that graph, no supply-chain or proprietary signal data is available.
Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples
Per the Butterfly Supply-Chain Graph, supply_chain is NONE, butterfly_links is empty, and proprietary_signals is empty. Upstream and downstream dependency mapping is not available in source data. Sector correlation and second-order bottleneck data are not available in source data. From the news wire, the Benzinga headline references weak U.S. demand and rising costs as pressure points an investor may monitor, and the Hill's headline points to premium pricing as a profit lever; beyond these attributed headlines, no further ripple analysis can be supported by source data.
Open Questions
- What is the specific composition of institutional 13F holders and options positioning behind the Whale 13F Flow pillar score of 15 / 20?
- What are the individual SEC Form 4 and Congressional PTR transactions underlying the Insider Conviction pillar score of 14 / 20?
- What EPS figures were reported for FY 2023 through FY 2025, since the source lists EPS as N/A for each period?
- What is the cash balance for FY 2023, and what drives the Debt/Equity reading of 8.5 given reported debt figures?
- What analyst consensus rating and price targets apply, given that analyst data is not available?
CL Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Colgate-Palmolive Company (CL) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
24/7 Wall St. report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
Benzinga report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.
CL Bull vs. Bear Conversation Board — What's Your Call at $95.29?
🔥 Official Bull vs. Bear Debate: Is CL (B- • RQD 70/100) a Buy at $93.16?
Welcome to the CL (Colgate-Palmolive Company) Roar Pit. Current RQD Composite is 70/100 (Roarable Buy — Sound Institutional Accumulation) in Package Goods/Cosmetics. Bulls point to capital efficiency (44.0% ROIC), while bears focus on valuation multiple compression (34.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on CL — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on CL, but look at what you are paying: 34.8x trailing P/E with 60.1% gross margins. Unless Colgate-Palmolive Company expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
CL cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on CL, the market is fixating on short-term headline noise in Package Goods/Cosmetics and ignoring the balance sheet and cash flow trajectory. At $93.16 (52-wk range $74.55 - $99.33), any beat on forward guidance forces shorts and underweight funds to chase.